id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-2330-0035,FDA,FDA-2019-D-2330,Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers Guidance for Industry,Other,Guidance,2021-12-27T05:00:00Z,2021,12,2021-12-27T05:00:00Z,,2024-11-12T23:35:32Z,,1,0,0900006484efda35
FDA-2019-D-2330-0034,FDA,FDA-2019-D-2330,Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2021-12-27T05:00:00Z,2021,12,2021-12-27T05:00:00Z,,2021-12-27T14:29:13Z,2021-28051,0,0,0900006484efd807
FDA-2019-D-2330-0004,FDA,FDA-2019-D-2330,Request for Extension from Society of Toxicologic Pathology,Other,Request for Extension,2019-08-27T04:00:00Z,2019,8,2019-08-27T04:00:00Z,,2019-08-27T20:21:35Z,,0,0,0900006483e6e813
FDA-2019-D-2330-0002,FDA,FDA-2019-D-2330,"Pathology Peer Review in Nonclinical Toxicology Studies: Questions and
Answers Guidance for Industry; Draft Guidance",Other,Guidance,2019-08-01T04:00:00Z,2019,8,2019-08-01T04:00:00Z,2019-11-01T03:59:59Z,2024-11-12T23:05:33Z,,1,0,0900006483dde8ab
FDA-2019-D-2330-0001,FDA,FDA-2019-D-2330,"Pathology Peer Review in Nonclinical Toxicology Studies: Questions and
Answers; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2019-08-01T04:00:00Z,2019,8,2019-08-01T04:00:00Z,2019-10-01T03:59:59Z,2019-10-05T01:04:09Z,2019-16361,0,0,0900006483dddb19